Is there a difference in systemic lupus erythematosus with and without Raynaud’s phenomenon?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190:104–111
Rothfield NF (1989) Systemic lupus erythematosus: clinical aspects and treatment. In: McCarthy EJ (ed) Arthritis and allied conditions: a textbook of rheumatology, 11th edn. Lea & Febiger, Philadelphia, pp 1022–1048
Rothfield N, Sontheimer RD, Bernstein M (2006) Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol 24:348–362
Costner MI, Sontheimer RD (2003) Lupus erythematosus. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Fitzpatrick’s dermatology in general medicine, 6th edn. McGraw-Hill, New York, pp 1677–1693
Cervera R, Khamashta MA, Font J, Sebastiani GD, Lavilla P, Doménech I, Aydintug AO, Jedryka-Góral A, de Ramón E et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72:113–124
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthr Rheum 40:1725
Maricq HR (1981) Widwfield capillary microscopy, technique and rating scale for abnormalities in scleroderma and related disorders. Arthr Rheum 24(9):1159–1165
Damjanov N, Pavlov S, Radosavljevic V, Ostojic P, Curcic A (1998) Prognostic significance of capillaroscopic findings in subjects with Raynaud’s phenomenon. Acta Rheum Belgrad 28:12–17
Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160
Stefanidou S, Benos A, Galanopoulou V, Chatziyannis I, Kanakoudi F, Aslanidis S, Boura P, Sfetsios T, Settas L, Katsounaros M, Papadopoulou D, Giamalis P, Dombros N, Chatzistilianou M, Garyfallos A (2011) Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male: female comparison. Lupus 20:1090–1094
Richter JG, Sander O, Schneider M, Klein-Weigel P (2010) Diagnostic algorithm for Raynaud’s phenomenon and vascular skin lesions in systemic lupus erythematosus. Lupus 19:1087–1095
Lian F, Chen D, Wang Y, Ye Y, Wang X, Zhan Z, Xu H, Liang L,Yang X (2011) Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus. Rheumatol Int. doi: 10.1007/s00296-011-1880-4
Padovan M, Castellino G, Bortoluzzi A, Caniatti L, Trotta F, Govoni M (2012) Factors and comorbidities associated with central nervous systemic involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center. Rheumatol Int 32:129–135
Mathieu A, Sanna G, Passiu G, Cauli A, Piga M (2000) Raynaud’s syndrome in systemic lupus erythematosus. Lancet 355:1102–1103
Ferraccioli G, Di Poi E, Di Gregorio F, Giacomuzzi F, Guerra U (1999) Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud’s syndrome. Lancet 354:2135–2136
Kasparian A, Floros A, Gialafose E, Kanakis M, Tassiopoulos S, Kafasi N, Vaiopoulos G (2007) Raynaud’s phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 16:505–508
Riccieri V, Spadaro A, Ceccarelli F, Scrivo R, Germane V, Valesini G (2005) Nailfold capillaroscopy changes in systemic lupus erythematosus correlations with disease activity and autoantibody profile. Lupus 14:521–525
Ingegnoli F, Zeni S, Meani L, Soldi A, Lurati A, Fantini F (2005) Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 11:295–298
Lefford F, Edwards JC (1986) Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 45:741–749
Lee P, Leung Y-KF, Alderdice C, Armstrong KS (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10(6):930–938
Kabasakal Y, Elvins DM, Ring EFJ, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512
Bongard O, Bounaameax H, Miescher PA, Moeroose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4:142–144
D'Angelo WA, Medsger TA Jr, Sharp GC, Wolfe JF (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthrtitis Rheum 23:183–189
Furtado RN, Pucinelli ML, Cristo VV, Andrade LE, Sato EI (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti U1-RNP antibodies and Raynaud’s phenomenon in SLE patients. Lupus 11:35–41
Pavlov-Dolijanovic S, Damjanov N, Stojanovic R, Vujasinovic Stupar N, Stanisavljevic D (2011) Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud’s phenomenon. Rheumatol Int. doi: 10.1007/s00296-011-2109-2